Common Contracts
7 similar Non-Qualified Stock Option Agreement contracts by CRISPR Therapeutics AG, Elixir Pharmaceuticals, Inc., HOOKIPA Pharma Inc., others
FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER THE MID-AMERICA APARTMENT COMMUNITIES, INC. 2023 OMNIBUS INCENTIVE PLANNon-Qualified Stock Option Agreement • July 27th, 2023 • Mid-America Apartments, L.P. • Real estate investment trusts
Pursuant to the Mid-America Apartment Communities, Inc. 2023 Omnibus Incentive Plan as amended through the date hereof (the “Plan”), Mid-America Apartment Communities, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER THE HOOKIPA PHARMA INC. 2018 STOCK OPTION AND INCENTIVE PLANNon-Qualified Stock Option Agreement • April 8th, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Pursuant to the HOOKIPA Pharma Inc. 2019 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), HOOKIPA Pharma Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.0001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER THE CRISPR THERAPEUTICS AGNon-Qualified Stock Option Agreement • June 1st, 2018 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
Pursuant to the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), CRISPR Therapeutics AG (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value CHF 0.03 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER THE CRISPR THERAPEUTICS AG AMENDED AND RESTATED 2016 STOCK OPTION AND INCENTIVE PLANNon-Qualified Stock Option Agreement • November 8th, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
Pursuant to the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), CRISPR Therapeutics AG (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value CHF 0.03 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER MEVION MEDICAL SYSTEMS, INC.Non-Qualified Stock Option Agreement • October 10th, 2014 • Mevion Medical Systems, Inc. • Electromedical & electrotherapeutic apparatus
Pursuant to the Mevion Medical Systems, Inc. 2014 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Mevion Medical Systems, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER THE MID-AMERICA APARTMENT COMMUNITIES, INC.Non-Qualified Stock Option Agreement • November 7th, 2013 • Mid America Apartment Communities Inc • Real estate investment trusts
Pursuant to the Mid-America Apartment Communities, Inc. 2013 Stock Incentive Plan as amended through the date hereof (the “Plan”), Mid-America Apartment Communities, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER THE ELIXIR PHARMACEUTICALS, INC.Non-Qualified Stock Option Agreement • December 18th, 2007 • Elixir Pharmaceuticals, Inc. • Pharmaceutical preparations
Pursuant to the Elixir Pharmaceuticals, Inc. 2007 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Elixir Pharmaceuticals, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
